Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study

NCT06642831 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 380

Last updated 2024-10-15

No results posted yet for this study

Summary

The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women.

Conditions

  • Polycystic Ovarian Syndrome (PCOS)

Sponsors & Collaborators

  • Roche Diagnostics International AG

    collaborator INDUSTRY
  • University Hospital Erlangen

    lead OTHER

Principal Investigators

  • Ralf Dittrich, Prof. · University Hospital Erlangen

Eligibility

Min Age
15 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2026-12-31
Completion
2027-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06642831 on ClinicalTrials.gov